New Method Kills Cancer Cells Resistant to a KRAS Inhibitor
New research from NYU Langone’s Perlmutter Cancer Center suggests that therapies targeted at KRAS mutations may also work as immunotherapies.
New Study Has Implications for Treatment of Speech Disorders
Work by NYU School of Medicine researchers and published in the journal Science examines the brain mechanisms behind fast vocal turn-taking.
New York City Health and Nutrition Examination Survey (NYC HANES) 2004 and 2013-14: Part III – Data analysis using SAS and SUDAAN
... to your colleagues! • Contacting SUDAAN – Go to the technical assistance web page, or – Send an email ... survey years – Diabetes defined as: • Diagnosed diabetes: if participant was ever told by a doctor ...
NYU Langone Has ‘A’ Fall 2021 Leapfrog Hospital Safety Grade
For the second time, all of NYU Langone’s hospitals receive “A” ratings in the fall 2021 Leapfrog Hospital Safety Grade.
NYU Langone Has Made In-Person Care Safe Amid the Pandemic
The COVID-19 pandemic is no reason to delay urgent and routine medical care—NYU Langone has taken every precaution to ensure patient safety.
NYU Langone Has Top Kidney, Lung Transplant Programs in U.S.
The NYU Langone Transplant Institute has nation’s highest-quality kidney and lung transplant programs, according to federal quality data.
NYU Langone Has Top Kidney, Lung Transplant Programs in U.S.
The NYU Langone Transplant Institute has the nation’s highest-quality kidney and lung transplant programs, according to federal data.
Pandemic Has Created Perfect Storm for Mental Health Needs
NYU Langone’s Department of Psychiatry chair, Dr. Charles Marmar, speaks to the increased need for accessible and equitable mental healthcare.
Patient Who Has Cerebral Palsy Walks Across Graduation Stage
Jessica Huang walked across her college graduation stage with her physical therapists from NYU Langone’s Rusk Rehabilitation, Katie Knote and Cassandra Ruff.
Perlmutter Cancer Center’s Phase 1 Program Has New Director
Dr. Kristen Spencer directs the Phase 1 Developmental Therapeutics Program at NYU Langone’s Perlmutter Cancer Center.